$KTEL
KonaTel, Inc.

2023 Q1 Form 10-Q Financial Statement

#000151597123000072 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $4.032M $4.228M
YoY Change -4.64% 76.69%
Cost Of Revenue $3.030M $2.581M
YoY Change 17.41% 74.17%
Gross Profit $1.002M $1.647M
YoY Change -39.18% 80.79%
Gross Profit Margin 24.85% 38.96%
Selling, General & Admin $1.608M $1.458M
YoY Change 10.33% 70.42%
% of Gross Profit 160.54% 88.5%
Research & Development $143.5K $134.6K
YoY Change 6.63%
% of Gross Profit 14.33% 8.17%
Depreciation & Amortization $3.088K $4.120K
YoY Change -25.05% -98.07%
% of Gross Profit 0.31% 0.25%
Operating Expenses $1.755M $1.597M
YoY Change 9.93% 49.35%
Operating Profit -$753.2K $50.71K
YoY Change -1585.3% -132.13%
Interest Expense $161.5K -$24.03K
YoY Change -772.08% 972.77%
% of Operating Profit -47.39%
Other Income/Expense, Net -$161.5K -$71.12K
YoY Change 127.08% -2.09%
Pretax Income -$914.7K -$44.45K
YoY Change 1957.82% -80.9%
Income Tax
% Of Pretax Income
Net Earnings -$914.7K -$44.45K
YoY Change 1957.81% -80.9%
Net Earnings / Revenue -22.69% -1.05%
Basic Earnings Per Share -$0.02 $0.00
Diluted Earnings Per Share -$0.02 -$1.068K
COMMON SHARES
Basic Shares Outstanding 42.38M shares 41.62M shares
Diluted Shares Outstanding 42.38M shares 41.62M shares

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.596M $1.453M
YoY Change 9.85% 155.18%
Cash & Equivalents $1.596M $1.453M
Short-Term Investments
Other Short-Term Assets $164.00 $33.30K
YoY Change -99.51% 1598.98%
Inventory $690.9K $634.7K
Prepaid Expenses $35.17K
Receivables $1.202M $982.1K
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.525M $3.103M
YoY Change 13.59% 188.36%
LONG-TERM ASSETS
Property, Plant & Equipment $33.45K $44.77K
YoY Change -25.29% -32.78%
Goodwill
YoY Change
Intangibles $634.3K
YoY Change
Long-Term Investments $10.00K
YoY Change
Other Assets $74.54K $154.3K
YoY Change -51.69% -10.45%
Total Long-Term Assets $1.262M $994.2K
YoY Change 26.94% -41.92%
TOTAL ASSETS
Total Short-Term Assets $3.525M $3.103M
Total Long-Term Assets $1.262M $994.2K
Total Assets $4.787M $4.097M
YoY Change 16.83% 46.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.400M $1.068M
YoY Change 31.02% 8.99%
Accrued Expenses $120.7K $37.16K
YoY Change 224.7% -62.27%
Deferred Revenue
YoY Change
Short-Term Debt $3.114M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.635M $1.106M
YoY Change 319.23% -3.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $150.0K
YoY Change -100.0% 0.0%
Other Long-Term Liabilities $427.3K $127.0K
YoY Change 236.54% -23.04%
Total Long-Term Liabilities $427.3K $277.0K
YoY Change 54.28% -12.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.635M $1.106M
Total Long-Term Liabilities $427.3K $277.0K
Total Liabilities $5.062M $1.383M
YoY Change 266.15% -5.08%
SHAREHOLDERS EQUITY
Retained Earnings -$9.213M
YoY Change
Common Stock $42.48K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$275.5K $2.715M
YoY Change
Total Liabilities & Shareholders Equity $4.787M $4.097M
YoY Change 16.83% 46.96%

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$914.7K -$44.45K
YoY Change 1957.81% -80.9%
Depreciation, Depletion And Amortization $3.088K $4.120K
YoY Change -25.05% -98.07%
Cash From Operating Activities -$500.8K $520.1K
YoY Change -196.3% -554.06%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $41.25K
YoY Change
NET CHANGE
Cash From Operating Activities -$500.8K 520.1K
Cash From Investing Activities
Cash From Financing Activities $41.25K
Net Change In Cash -$459.6K $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$500.8K $520.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000845819
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
CY2022Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-10171
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
KonaTel, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
80-0973608
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
500 N. Central Expressway
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Ste. 202
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Plano
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75074
CY2023Q1 dei City Area Code
CityAreaCode
214
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
323-8410
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42483220 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1596048 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2055634 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1202255 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1510118 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
690868 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
526337 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
35170 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
61241 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
164 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
164 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
3524505 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4153494 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33448 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36536 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
634251 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
634251 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
519894 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
553686 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
74542 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
73883 usd
CY2023Q1 ktel Total Other Assets
TotalOtherAssets
1228687 usd
CY2022Q4 ktel Total Other Assets
TotalOtherAssets
1261820 usd
CY2023Q1 us-gaap Assets
Assets
4786640 usd
CY2022Q4 us-gaap Assets
Assets
5451850 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1399838 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1348931 usd
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
3114330 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
3070947 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
120658 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
118382 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4634826 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4538260 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
427299 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
458227 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
427299 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
458227 usd
CY2023Q1 us-gaap Liabilities
Liabilities
5062125 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4996487 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42483220 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42483220 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42240406 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42240406 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
42483 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
42240 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8894593 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8710987 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9212561 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8297864 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-275485 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
455363 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4786640 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5451850 usd
CY2023Q1 us-gaap Revenues
Revenues
4031719 usd
CY2022Q1 us-gaap Revenues
Revenues
4227856 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
3029840 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
2580595 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1001879 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
1647261 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1139546 usd
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1132313 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1700 usd
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
642 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
14 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
55 usd
CY2023Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
300498 usd
CY2022Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
149170 usd
CY2023Q1 us-gaap Other General Expense
OtherGeneralExpense
57045 usd
CY2022Q1 us-gaap Other General Expense
OtherGeneralExpense
35687 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3088 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4117 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40234 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
60918 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
37517 usd
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
47670 usd
CY2023Q1 ktel Application Development Costs
ApplicationDevelopmentCosts
143529 usd
CY2022Q1 ktel Application Development Costs
ApplicationDevelopmentCosts
134605 usd
CY2023Q1 us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
31903 usd
CY2022Q1 us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
31379 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1755074 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
1596556 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-753195 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
50705 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
161502 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
24030 usd
CY2022Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
71124 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-161502 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-95154 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-914697 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44449 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42375917 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41615406 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42375917 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41615406 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
455363 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
41250 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
142599 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-914697 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-275485 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2607335 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
151759 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44449 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2714645 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-914697 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44449 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3088 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4117 usd
CY2023Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-43383 usd
CY2023Q1 us-gaap Provision For Other Losses
ProvisionForOtherLosses
14 usd
CY2022Q1 us-gaap Provision For Other Losses
ProvisionForOtherLosses
55 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
142599 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
151759 usd
CY2023Q1 ktel Change In Right Of Use Asset
ChangeInRightOfUseAsset
-33792 usd
CY2022Q1 ktel Change In Right Of Use Asset
ChangeInRightOfUseAsset
-22604 usd
CY2023Q1 ktel Change In Lease Liability
ChangeInLeaseLiability
-28650 usd
CY2022Q1 ktel Change In Lease Liability
ChangeInLeaseLiability
-22979 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-307848 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-292520 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
164531 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
67810 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-25412 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-46328 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
50906 usd
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
137939 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-500836 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
520084 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
41250 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41250 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-459586 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
520084 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2055634 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
932785 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1596048 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1452869 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
118125 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
5121 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1050144 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2194079 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-914697 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44449 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42375917 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41615406 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42375917 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41615406 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
the Company had four (4) properties with lease terms in excess of one (1) year. Of these four (4) leases, two (2) leases expire in 2025, one (1) lease expires in 2026, and one (1) lease expires in 2030
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
547957 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zTbDCq8T6LW" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Concentrations of Credit Risk</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of receivables, cash and cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All cash and cash equivalents are held at high credit financial institutions. These deposits are generally insured under the FDIC’s deposit insurance coverage; however, from time to time, the deposit levels may exceed FDIC coverage levels.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_91E_eus-gaap--TradeAccountsReceivableMember_zlgbceyk3Xf9" style="display: none">Trade Account Receivables</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_91D_eus-gaap--SalesRevenueNetMember_z7H6iqMLVGni" style="display: none">Sales Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has a concentration of risk with respect to trade receivables from customers and cellular providers. As of March 31, 2023, the Company had a significant concentration of receivables (defined as customers whose receivable balances are greater than 10% of total receivables) due from two (2) customers in the amount of $<span id="xdx_906_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerOneMember_zgjSaNlBAHAg" title="Receivables, concentration">738,706</span>, or <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerOneMember_zEauqeAZEgC9" title="Concentration risk">61.4</span>%, and $<span id="xdx_90D_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerTwoMember_zmE4UeUGByDj" title="Receivables, concentration">223,604</span>, or <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerTwoMember_zqIEXFQfxsSg" title="Concentration risk">18.6</span>%. It should be noted that the largest customer is the FCC. As of December 31, 2022, the Company had a significant concentration of receivables from two (2) customers in the amounts of $<span id="xdx_90E_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerOneMember_zhrQ3h6ap0h8" title="Receivables, concentration">859,334</span>, or <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerOneMember_zZmwd7jLjMBk" title="Concentration risk">57.0</span>%, and $<span id="xdx_90F_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerTwoMember_zVIPtSqHXGpj" title="Receivables, concentration">255,136</span>, or <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerTwoMember_zkIHBvM0ATSi" title="Concentration risk">16.9</span>%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q1 us-gaap Inventory Net
InventoryNet
690868 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
526337 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
461611 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
461611 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
428163 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
425075 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33448 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36536 usd
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
115459 usd
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
155324 usd
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
129543 usd
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
65967 usd
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
54000 usd
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
144000 usd
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
664293 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
116336 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
547957 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
120658 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
427299 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P66M9D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0678 pure
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
43275 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
30897 usd
CY2023Q1 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
1135962 usd
CY2022Q4 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
1135962 usd
CY2023Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2407001 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2407001 usd
CY2023Q1 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
634251 usd
CY2022Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
634251 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3542963 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3542963 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
634251 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
634251 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
634251 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
634251 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 number
CY2023Q1 us-gaap Revenues
Revenues
4031719 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1001879 usd
CY2023Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3088 usd
CY2023Q1 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
CY2022Q1 us-gaap Revenues
Revenues
4227856 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
1647261 usd
CY2022Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
4117 usd
CY2022Q1 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
142599 usd
CY2022Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
151759 usd
CY2023Q1 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
1412615 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y8M8D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4405000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.59
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y2M19D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2260138 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.85
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
287500 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.26
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
127025 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4167500 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.62
CY2023Q1 ktel Weighted Average Remaining Life At End Of Period
WeightedAverageRemainingLifeAtEndOfPeriod
P3Y8M8D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
410388 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1050144 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.45
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y29D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
279114 usd

Files In Submission

Name View Source Status
ktel-20230331_cal.xml Edgar Link unprocessable
0001515971-23-000072-index-headers.html Edgar Link pending
0001515971-23-000072-index.html Edgar Link pending
0001515971-23-000072.txt Edgar Link pending
0001515971-23-000072-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ktel-20230331.xsd Edgar Link pending
ktel10q033123.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ktel-20230331_lab.xml Edgar Link unprocessable
ktel-20230331_def.xml Edgar Link unprocessable
ktel-20230331_pre.xml Edgar Link unprocessable
ktel10q033123_htm.xml Edgar Link completed